1. Anti-HBV Therapeutic Potential of Small Molecule 3,5,6,7,3',4'-Hexamethoxyflavone in Vitro and in Vivo. Tan, M., F. Ren, and X. Yang. Virology, 2021. 560: p. 66-75. PMID[34051476].
[PubMed]. HBV_07_2021.
2. Significant in-vitro and in-vivo Inhibition of HBsAG and HBV pgRNA with ASC42, a Novel Non-steroidal FXR Agonist. Wu, J.Z., X.D. Li, H.D. He, and Q. Zhou. Journal of Hepatology, 2021. 75: p. S703-S704. ISI[000667753802012].
[WOS]. HBV_07_2021.
Patent Citations
This month, no relevant HBV patents were identified.